AGN vs NEU

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

AGN

ARGENICA FPO [AGN]

45LOW

NEU

NEUREN FPO NZ [NEU]

47LOW

Score Breakdown

AGN NEU
Technical
48
61
Catalyst
50
50
Sentiment
50
50
Fundamental
34
62
Momentum
22
26
Risk Gate
42
43

Key Metrics

AGN Metric NEU
$18.0MMarket Cap$2.1B
502KAvg Volume (20d)725K
N/AShort Interest+4.9%
$0.77052-Week High$22.985
$0.08752-Week Low$11.000
+0.0%Daily Change+0.2%
$0.140Reference Price$16.530
-117.8%ROE+8.7%
N/AProfit Margin+47.1%

Active Signals

AGN Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Pressing against the upper Bollinger Band — extended and may need to cool off
On a tear — up 33.3% over the last 5 days
Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Below the 200-day average — the long-term trend is still working against it
Low cash runway (2 quarters) - dilution risk

NEU Signals

Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)
Piotroski F-Score strong (7/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
Earnings in sharp decline (-88% QoQ)

Ask Scout AI to compare AGN and NEU in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

AGN vs PEB →AGN vs PHX →AGN vs PYC →AGN vs RHY →AGN vs TRI →
AGN Full Analysis → NEU Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).